戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 436作成日:2026年10月23日

1-Bromo-4-iodobenzene → 1-(4-Bromophenyl)-cis-3,5-dimethylpiperazine

https://huagongshe.com/ja/reaction/436

反応式

関与物質

役割名称HCID仕込み量
反応物1-Bromo-4-iodobenzeneHCID 11522—
反応物rel-(2R,6S)-2,6-dimethylpiperazineHCID 6950261—
試薬Sodium t-butoxideHCID 23676156—
触媒1,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)HCID 636044—
触媒Palladium (II) acetateHCID 4144353—
溶媒1,4-DioxaneHCID 31275—
生成物1-(4-Bromophenyl)-cis-3,5-dimethylpiperazineHCID 6673036144.14%

反応条件

温度90 °C

反応手順

sodium 2-methylpropan-2-olate (0.510 g, 5.30 mmol) was added to (2R,6S)-2,6-dimethylpiperazine (0.605 g, 5.30 mmol) in dioxane (40 mL) at 21°C under nitrogen. Stirred for 5 mins. 1-bromo-4-iodobenzene (1 g, 3.53 mmol) added, followed by diacetoxypalladium (0.079 g, 0.35 mmol) and (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (0.409 g, 0.71 mmol). Reaction evacuated and refilled with nitrogen several times. Heated at 90C for 18hours. left to cool o/w. The reaction mixture was diluted with EtOAc (250 mL), and washed sequentially with water (150 mL). The organic layer was dried over Na2SO4, filtered and evaporated to afford crude product. The crude product was purified by flash silica chromatography, elution gradient 0 to 30% MeOH in EtOAc. Pure fractions were evaporated to dryness to afford (3S,5R)-1-(4-bromophenyl)-3,5-dimethylpiperazine (0.420 g, 44.1 %) as a yellow solid.

情報源と証拠

出典データセット750 AstraZeneca ELN dataset
ORD IDord-609b92e7f381461a936ff9653aaca797
出典メモ750 AstraZeneca ELN dataset